Avacta Group Plc

Avacta Group PLC is a UK-based clinical-stage biotechnology company that develops innovative cancer therapies and diagnostic tests. It aims to improve outcomes for cancer patients through novel and targeted treatment and detection approaches. Functioning in the biotechnology sector, the company leverages its proprietary platforms, such as Affimer and pre|CISION, to develop targeted cancer therapeutics and diagnostic reagents. Its goal is to deliver more effective, safer, and more precise solutions for patients and healthcare. Track the share price of AVCT.L by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.